HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter T Scardino Selected Research

Margins of Excision

1/2022Clinical utility of subclassifying positive surgical margins at radical prostatectomy.
1/2019In Organ-confined Prostate Cancer, Tumor Quantitation Not Found to Aid in Prediction of Biochemical Recurrence.
11/2017Contemporary Patterns of Care and Outcomes of Men Found to Have Lymph Node Metastases at the Time of Radical Prostatectomy.
4/2014Do margins matter? The influence of positive surgical margins on prostate cancer-specific mortality.
1/2014Long-term outcomes of patients with lymph node metastasis treated with radical prostatectomy without adjuvant androgen-deprivation therapy.
4/2013Prognostic impact of subclassification of radical prostatectomy positive margins by linear extent and Gleason grade.
9/2012Long-term outcomes after high-dose postprostatectomy salvage radiation treatment.
8/2011Prognostic significance of lymphovascular invasion in radical prostatectomy specimens.
11/2010Ethnic variation in pelvimetric measures and its impact on positive surgical margins at radical prostatectomy.
11/2010Location and number of positive surgical margins as prognostic factors of biochemical recurrence after salvage radiation therapy after radical prostatectomy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peter T Scardino Research Topics

Disease

214Prostatic Neoplasms (Prostate Cancer)
01/2022 - 02/2002
124Neoplasms (Cancer)
01/2022 - 02/2002
31Margins of Excision
01/2022 - 02/2002
30Neoplasm Metastasis (Metastasis)
08/2015 - 02/2002
18Disease Progression
01/2022 - 04/2003
17Lymphatic Metastasis
01/2019 - 02/2002
14Extranodal Extension
12/2014 - 02/2002
4Adenocarcinoma
01/2022 - 03/2004
4Erectile Dysfunction
01/2018 - 05/2008
4Carcinoma (Carcinomatosis)
01/2011 - 03/2004
3Urinary Incontinence
01/2021 - 12/2004
2Hemorrhage
07/2020 - 02/2016
2Carcinogenesis
02/2013 - 05/2009
2Fistula
08/2012 - 04/2002
2Venous Thrombosis (Deep-Vein Thrombosis)
07/2012 - 02/2004
2Pathologic Constriction (Stenosis)
06/2011 - 04/2002
1Acquired Immunodeficiency Syndrome (AIDS)
01/2022
1Bone Diseases (Bone Disease)
01/2017
1Breast Neoplasms (Breast Cancer)
11/2016
1Body Weight (Weight, Body)
10/2016
1Necrosis
10/2016
1Venous Thromboembolism
02/2016
1Embolism (Embolus)
07/2012
1Pulmonary Embolism
07/2012

Drug/Important Bio-Agent (IBA)

107Prostate-Specific Antigen (Semenogelase)IBA
01/2022 - 03/2002
22AndrogensIBA
01/2019 - 11/2003
14Kallikreins (Kallikrein)IBA
01/2020 - 11/2007
11Biomarkers (Surrogate Marker)IBA
01/2022 - 02/2007
8Peptide Hydrolases (Proteases)FDA Link
11/2016 - 12/2008
7Androgen Receptors (Androgen Receptor)IBA
01/2018 - 07/2007
7Choline (Choline Chloride)IBA
03/2017 - 10/2003
6CreatineIBA
05/2009 - 10/2003
5Dihydrotachysterol (AT 10)IBA
05/2012 - 02/2002
5Biological ProductsIBA
04/2011 - 10/2003
5Citric Acid (Citrate)FDA LinkGeneric
08/2005 - 10/2003
4AntigensIBA
01/2019 - 02/2002
4Protons (Proton)IBA
03/2017 - 10/2003
4Tissue Kallikreins (Tissue Kallikrein)IBA
11/2009 - 02/2003
3ParaffinIBA
01/2019 - 04/2003
3Indicators and Reagents (Reagents)IBA
01/2018 - 03/2004
3DNA (Deoxyribonucleic Acid)IBA
07/2014 - 02/2009
3Protein Isoforms (Isoforms)IBA
12/2008 - 01/2005
3Hormones (Hormone)IBA
08/2006 - 02/2004
3serum P-component (CIt)IBA
08/2005 - 10/2003
26H,8H- 3,4- dihydropyrimido(4,5- c)(1,2)oxazin- 7- oneIBA
09/2016 - 10/2003
2Kazal Pancreatic Trypsin InhibitorIBA
09/2014 - 06/2008
2Proteins (Proteins, Gene)FDA Link
11/2013 - 07/2007
2Phosphotransferases (Kinase)IBA
02/2013 - 05/2011
2Messenger RNA (mRNA)IBA
07/2010 - 04/2003
2beta-microseminoproteinIBA
05/2010 - 07/2007
2Transcription Factors (Transcription Factor)IBA
02/2009 - 04/2008
2Fluconazole (Zonal)FDA LinkGeneric
11/2008 - 11/2007
2Capsules (Microcapsules)IBA
03/2006 - 12/2003
2HydrogenIBA
03/2005 - 10/2003
2Phosphocreatine (Neoton)IBA
03/2005 - 10/2003
1GP 4 (GP4)IBA
01/2022
1Hemoglobins (Hemoglobin)IBA
07/2020
1BAY 86-7548IBA
01/2019
1Tacrolimus (Prograf)FDA LinkGeneric
01/2018
1Pharmaceutical PreparationsIBA
01/2017
1N-hydroxysuccinimide S-acetylthioacetate (SATA)IBA
11/2016
1mCherry fluorescent proteinIBA
10/2016
1CollagenIBA
10/2016
1padeliporfinIBA
10/2016
1Prostaglandins AIBA
02/2016
1AutoantibodiesIBA
11/2013
1AntibodiesIBA
11/2013
1gag Gene Products (gag Protein)IBA
11/2013
1Androgen Antagonists (Antiandrogens)IBA
11/2013
1IntegrinsIBA
02/2013
1KalininIBA
02/2013
1tyrosine receptor (receptor, tyrosine)IBA
02/2013
1TESIBA
07/2012
1Docetaxel (Taxotere)FDA Link
03/2012
1taxaneIBA
03/2012

Therapy/Procedure

161Prostatectomy (Retropubic Prostatectomy)
01/2022 - 02/2002
58Therapeutics
01/2022 - 02/2002
36Radiotherapy
01/2021 - 04/2003
11Lymph Node Excision (Lymph Node Dissection)
01/2021 - 02/2002
7Castration
11/2013 - 06/2005
6Salvage Therapy
01/2021 - 11/2003
6Aftercare (After-Treatment)
08/2012 - 05/2002
5Adjuvant Radiotherapy
01/2019 - 10/2005
4Drug Therapy (Chemotherapy)
03/2012 - 02/2004
3Photochemotherapy (Photodynamic Therapy)
10/2018 - 12/2008
2Transurethral Resection of Prostate (TURP)
01/2022 - 01/2011
2Brachytherapy
01/2021 - 01/2016
2Chemoprevention
02/2016 - 09/2010
2Treatment Delay
01/2013 - 04/2009
2Operative Surgical Procedures
09/2011 - 11/2005
1Phototherapy (Light Therapy)
10/2018
1Combined Modality Therapy
01/2017
1Optical Fibers
10/2016
1Intravenous Infusions
10/2016
1Blood Transfusion (Blood Transfusions)
02/2016
1General Anesthesia
12/2014
1Anesthesia
12/2014
1Urinary Diversion (Ileal Conduit)
08/2012
1Cystectomy
08/2012
1Sutures (Suture)
02/2012